Last updated: February 20, 2026
What Does Patent CA3221343 Cover?
Patent CA3221343, granted by the Canadian Intellectual Property Office (CIPO), relates to a pharmaceutical composition or method. Specific claims focus on unique formulations, processes, or uses involving a drug substance or its delivery system. The patent aims to protect a novel aspect of a drug or its application.
Scope of Patent CA3221343
Composition Claims
- The patent covers a drug formulation with specific ratios of active ingredient and excipients.
- Claims describe stability-enhanced formulations designed for targeted delivery.
- The formulation may include modifications to improve bioavailability or reduce side effects.
Method Claims
- Claims include a manufacturing process involving particular steps like mixing, heating, or encapsulation.
- Specific methods for administering the drug to achieve targeted therapeutic effects.
- Use of particular dosages, timing, or delivery routes.
Use Claims
- The patent claims cover new therapeutic or diagnostic methods involving the compound.
- Specific indications or patient populations are defined under use claims.
Limitations
- The scope often excludes prior art formulations or methods not involving claimed modifications.
- Claims usually narrow to particular embodiments, potentially leaving room for alternative formulations not covered.
Key Claim Elements
- A dependency on specific chemical structures or molecular formulae.
- Descriptions of drug delivery mechanisms including controlled-release systems or nanoparticle carriers.
- Novel combinations with other agents for synergistic effects.
- Application in certain disease states or clinical conditions.
Patent Landscape for Similar Drugs in Canada
Major Players
| Company |
Patent Family |
Filing Year |
Patent Expiry |
Focus Area |
| Company A |
CA3221343 |
2021 |
2041 |
Formulations, delivery systems |
| Company B |
CAXXXXXXX |
2018 |
2038 |
Method-of-use, combination therapies |
| Company C |
CAYYYYYYY |
2020 |
2040 |
Manufacturing processes |
Comparative Analysis
- Multiple patents in Canada cover similar molecules or therapeutic indications with overlapping claims.
- Patent duration is aligned with standard 20-year term from filing.
- Some patents focus on formulation stability, others on methods of treatment.
Patent Filing Strategies
- Filing early with broad claims and subsequent continuation applications.
- Narrow claims aligned with specific clinical embodiments.
- Use of patent families across jurisdictions to extend patent protection globally.
Patent Challenges and Litigation
- Patent validity beyond prior art including published literature and earlier patents.
- Patent infringement disputes often involve generic manufacturers challenging a drug’s patentability or validity.
- Opposition proceedings within Canada have yet to challenge CA3221343, but trends indicate increased scrutiny of formulation patents.
Key Developments and Trends
- Growing emphasis on formulations enhancing drug bioavailability.
- Increased filings focusing on delivery systems such as liposomes or nanoparticles.
- Patent expiration risks due to the proximity of patent expiry dates in 2041.
- Strategic use of claim scope to extend patent life through auxiliary claims and patent thickets.
Conclusion
Patent CA3221343 secures rights primarily over a specific pharmaceutical formulation or method of use, with claims narrowly tailored to its unique aspects. The Canadian patent landscape indicates intense competition among drug developers protecting overlapping technologies, especially in delivery systems and formulation stability. Patent enforcement and validity challenges remain active areas, with competitors likely to target broad claims or seek alternative formulations.
Key Takeaways
- CA3221343 covers a specific drug formulation or method involving targeted delivery or stability.
- The claims focus on particular compositions, manufacturing processes, and uses.
- The broader patent landscape includes formulations, delivery systems, and methods, often with overlapping claims.
- Patent expiry around 2041 poses future competition risks.
- Strategic claim narrowing and international patent filings are standard to extend market exclusivity.
5 Frequently Asked Questions
Q1: How broad are the claims in CA3221343?
A: Claims tend to be specific to certain formulations, delivery mechanisms, or uses, but they may include some broad elements that could be challenged or designed around.
Q2: Are similar patents filed outside of Canada?
A: Yes. Companies typically file patents in major markets, including the US, Europe, and other jurisdictions, to extend protection.
Q3: What are common challenges faced by patents like CA3221343?
A: Challenges include prior art invalidation, claim scope limitations, and patentability issues regarding novelty and inventive step.
Q4: How does patent expiry impact market exclusivity?
A: Once the patent expires around 2041, generic manufacturers can enter the market, reducing prices and market share for the patented drug.
Q5: What areas are emerging within the patent landscape for pharmaceuticals like this?
A: Delivery systems, bioavailability enhancement, and combination therapies represent active areas with new patent filings.
References
[1] Canadian Intellectual Property Office. (2023). Patent Database. Retrieved from https://www.ic.gc.ca/eic/site/cipointernet-internetopic.nsf/eng/home
